Peter SCHROEER
Vice President Regulatory Affairs EMEA and Canada - Johnson & Johnson
Take off for the €2.4 Billion European Innovative Health Initiative Partnership
Wednesday 4 May 12:00 - 12:50
PETER SCHROEER has served since 2018 as the EMEAC Regional Vice President for Regulatory Affairs at Johnson & Johnson and is responsible for building an integrated team to ensure the Regulatory Affairs needs of the EMEAC region are fully met.
Prior to joining Johnson & Johnson, Peter began his career in the chemical industry, where he supported various start-ups of new innovations and manufacturing sides. In the Medical Devices industry, he set up manufacturing and servicing structures for active and passive medical devices, and lead Quality System as well as Product certification programs according to international standards, national and EU Medical Device regulations. He is a certified EOQ (European Organization for Quality) Quality Manager and auditor.
Since joining Johnson & Johnson in 1996, Peter served as the authorized representative for various Business Units, lead the Ethicon EMEA Quality and Regulatory group and established the MD&D regional regulatory affairs council. He established and led the EMEA ONE Ethicon and Global Surgery RA Teams and more recently lead the global regulatory policy and innovation team for the medical devices sector. As the Senior Director Policy Innovation, he was responsible for ensuring global regulatory policies were appropriately interpreted, effectively communicated and efficiently implemented in the Johnson & Johnson Medical Devices companies.
Peter holds an Engineering Diploma from the University of Münster - Steinfurt (Fachhochschule Münster) and serves as an active member of MedTech Europe where he is the Vice Chair of the Regulatory Affairs Council, chair of the Reuse Task Force and an active member of a number of other working groups.
Peter is a published author for regulatory affairs topics and as such is often requested to speak as an expert around the world, including presentations in the European Union's Parliament.